Charu Sabharwal, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Todd J. Belanger, Bradford D. Gessner, . . . Wendy Watson. (2022). Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease. Taylor & Francis Group.
Chicago Style (17th ed.) CitationCharu Sabharwal, et al. Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Adults 18 to 64 Years Old with Medical Conditions and Other Factors That Increase Risk of Pneumococcal Disease. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationCharu Sabharwal, et al. Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Adults 18 to 64 Years Old with Medical Conditions and Other Factors That Increase Risk of Pneumococcal Disease. Taylor & Francis Group, 2022.